| REGENXBIO INC. DL-,0001 |
| USA |
| Gesundheit |
| US75901B1070 / A140E0 |
| RB0 (Frankfurt) / RGNX (NASDAQ) |
| FRA:RB0, ETR:RB0, RB0:GR, NASDAQ:RGNX |
| - |
| https://www.regenxbio.com.. |
|
Regenxbio Inc. is a biotechnology company focused ..
>Volltext.. |
| 439.62 Mio. EUR |
| 434.47 Mio. EUR |
| 136.54 Mio. EUR |
| -117.79 Mio. EUR |
| -150.59 Mio. EUR |
| -2.95 EUR |
| 226.96 Mio. EUR |
| 49.77 Mio. EUR |
| -87.43 Mio. EUR |
| 2.2 |
| 81.51% |
| 29.31% |
| - |
| - |
| - |
| - |
| REGENXBIO |
| 10.02.26 |
|